Revalia Bio

Revalia Bio transforms donated, non-transplantable human organs and tissues into high-fidelity biological datasets, using AI to accelerate drug and device development. The company has built "The Human Data Stack" — infrastructure spanning data generation, ingestion, integration, interpretation, and delivery of decision-ready clinical insights for pharma, biotech, healthcare, and regulatory customers. Applications include safety signal detection, dose and target selection, patient selection, and mechanism-of-action studies. Founded by Greg Tietjen (CEO) and Jenna DiRito (COO), it generated first revenue in 2023 and raised seed funding in 2024. Backed by Sierra Ventures. As of this enrichment pass Revalia Bio publishes no public developer portal, API, SDK, or technical surface — it is a B2B research-services company, not a developer platform.

Revalia Bio is profiled on the APIs.io network. Tagged areas include Company, Biotech, AI, Drug Development, and Medical Devices.

🌐 Visit website 📡 Source on GitHub
13.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechAIDrug DevelopmentMedical DevicesClinical DataLife SciencesTranslational Science

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/revalia-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Revalia Bio Domain Security

TLSv1.3

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: revalia-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/revalia-bio.png
name: Revalia Bio
description: Revalia Bio transforms donated, non-transplantable human organs and tissues into high-fidelity biological datasets,
  using AI to accelerate drug and device development. The company has built "The Human Data Stack" — infrastructure spanning
  data generation, ingestion, integration, interpretation, and delivery of decision-ready clinical insights for pharma, biotech,
  healthcare, and regulatory customers. Applications include safety signal detection, dose and target selection, patient selection,
  and mechanism-of-action studies. Founded by Greg Tietjen (CEO) and Jenna DiRito (COO), it generated first revenue in 2023
  and raised seed funding in 2024. Backed by Sierra Ventures. As of this enrichment pass Revalia Bio publishes no public developer
  portal, API, SDK, or technical surface — it is a B2B research-services company, not a developer platform.
url: https://raw.githubusercontent.com/api-evangelist/revalia-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- sierra-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotech
- AI
- Drug Development
- Medical Devices
- Clinical Data
- Life Sciences
- Translational Science
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://revaliabio.com/
- type: PrivacyPolicy
  url: https://revaliabio.com/privacy-policy
- type: TermsOfService
  url: https://revaliabio.com/terms-of-service
- type: DomainSecurity
  url: security/revalia-bio-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1